期刊文献+

某院急诊注射用质子泵抑制剂的临床应用分析 被引量:6

Analysis of clinical application of proton pump inhibitor for injection in emergency patients
原文传递
导出
摘要 目的:对某院急诊注射用质子泵抑制剂(PPIs)的使用情况进行分析,为临床合理用药提供参考。方法:采用回顾性调查研究的方法,检索某院HIS,获取2015年7月份使用过注射用PPIs的急诊患者处方,依据SAHP(美国医院药师协会)指南及药品说明书对其临床应用进行合理性分析。结果:在1 754份处方中,统计结果显示某院急诊使用PPIs注射剂的临床诊断不符合使用指征占比24.7%,用法用量不合理的处方占比7.5%,联合用药不合理占比为1.7%,老年患者使用潘妥洛克日剂量超40 mg一项为5.4%,具有统计学意义,其合理性有待进一步讨论研究。结论:某院急诊科使用注射用质子泵抑制剂存在不合理现象。为减轻患者经济负担及降低用药风险,临床医生应规范诊疗行为,做到诊断与用药相适应,杜绝无正当理由超适应证用药;可通过处方点评或信息系统引导用药等干预措施来改善目前的用药现状。 OBJECTIVE To analyze use of proton pump inhibitors (PPIs) for injection in emergency and provide a reference for clinical rational drug use. METHODS Through HIS, patients received PPIs injection in emergency in July 2015 were select- ed. Prescriptions were retrospectively analyzed according to ASHP therapeutic guidelines and patient information leaflets. RE- SULTS A total of I 754 PPIs prescriptions in the emergency were included. Common prescribing errors: clinical diagnosis did not supported use of PPIs (24. 7%), wrong dosage and usage (7. 5%), irrational ratio of combined medication (1.7%). Old patients used Pantoloc more than 40mg, which accounted for 5.4% of medication error. It was statistically significant, and the rationality needed to be further discussed. CONCLUSION Part of PPIs use in emergency department is irrational. To reduce e- conomic burden and lower risk of medication, clinical physicians should standardize clinical diagnosis and therapy, make diagno-sis and medication consistent, avoid irrational off-label drug rise. Intervening measures including prescription comment and in- formation system guided medication can be used to improve current situations.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2016年第22期2023-2026,共4页 Chinese Journal of Hospital Pharmacy
关键词 质子泵抑制剂 差错处方 合理用药 prescription errors proton pump inhibitors rational drug use
  • 相关文献

参考文献7

二级参考文献55

  • 1翟所迪,毛璐,刘芳,甄建存,杨赴云,高晨,夏文彬,李程,王育琴,王淑洁,王海莲.多中心合理使用注射剂的对照干预研究[J].中国药学杂志,2005,40(2):155-156. 被引量:37
  • 2朱珠,蔡乐.质子泵抑制剂的安全性与合理应用[J].药物不良反应杂志,2005,7(2):81-90. 被引量:56
  • 3高萍,许国铭,邹多武.奥美拉唑和硫糖铝治疗十二指肠球部溃疡胃内24小时pH监测[J].中华消化杂志,1995,15(5):259-260. 被引量:20
  • 4许铁男.抗溃疡药 兰索拉唑[J].国外医药(合成药.生化药.制剂分册),1995,16(4):245-247. 被引量:15
  • 5陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 6Andersson T.Pharmacokinetics,metabolism and interactions of acid pump inhibitors.Focus on omeprazole[J].Clin Pharmacokinet,1996,31(1):9-28.
  • 7Meyer UA.Metabolic interactions of the proton-pump inhibitors lansoprazole and pantoprazole with other drugs[J].Eur J Gastroenterol Hepatol,1996,8(Suppl 1):S21-S25.
  • 8de Morais SMF,Wilkinson GR,Blaisdell J,et al.The major genetic defect responsible for the polymorphism of S-mephenytoin in humans[J].J Biol Chem,1994,269(22):15419-15422.
  • 9de Morais SMF,Wilkinson GR,Blaisdell J,et al.Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in japanese[J].Mol Pharmacol,1994,46(4):594-598.
  • 10Leiri l,Kubota T,Urae A,et al.Pharmacokinetics of omeprazole(a substrate of CYP2C19) and coparison with two mutant allales,CYP2C19m1 in exon5 and CYP2C19m2 in exon4,in Japanese subjects[J].Clin Pharmacol Ther,1996,59(6)∶647-653.

共引文献353

同被引文献65

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部